Fundamental Analysis
54 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +25.6% | +28.4% | 2 / 3 | +97.8% | +0.98 pp | -1.47 pp | +4.6% | 1.25 | 8.36 | 319 | +97,8% | 8,1 | +25,6% | 8.36 | 12.48 | −33,0% |
| Pts | 4 | 4 | 8 | 12 | 8 | 4 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 7.000 (close price on 2026-10-19)EPS (TTM): 837,7
Financial charts
1.Revenue & growth
VND bn319Q2/26
1.Revenue & growth
VND bn319Q2/26
2.Profit & growth
VND bn8,14Q2/26
3.Profit mix (Penman)
VND bn15,7Q2/26
4.Margins & cost structure
%5.6%Q2/26
5.Returns & cash cycle
% · days5.0%Q2/26
6.Earnings quality & cash
VND bn27,6Q2/26
7.Asset structure
VND bn820Q2/26
8.Funding & debt health
VND bn · times820Q2/26
9.Revenue backlog
VND bn6,11Q2/26
10.Valuation
times · %8,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %543Q2/26
Adjusted EPS growth, latest quarter
25.6%
Average adjusted EPS growth, 3 quarters
28.4%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26